MannKind (MNKD)
(Delayed Data from NSDQ)
$4.78 USD
-0.04 (-0.83%)
Updated May 24, 2024 04:00 PM ET
After-Market: $4.79 +0.01 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Brokerage Reports
MannKind Corporation [MNKD]
Reports for Purchase
Showing records 161 - 180 ( 228 total )
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
FY 1Q12 Earnings: Results Hampered by Slow Phase III Accrual
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
FY 1Q12 Earnings: Results Hampered by Slow Phase III Accrual
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Griffin Securities Updates Coverage of Mannkind Corporation (MNKD)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Griffin Securities Updates Coverage on MannKind Corp. (MNKD)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
4Q11 Earnings Call: Still Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
4Q11 Earnings Call: Still Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
3Q11 Earnings Call: Still Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
3Q11 Earnings Call: Still Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Corporation 3Q11 Earnings Call Preview: Awaiting Upcoming Key Milestones
Provider: RODMAN & RENSHAW, CO.
Analyst: KING M
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: MannKind Corporation
Industry: Medical - Biomedical and Genetics
Transfer of Coverage: Maintaining a Market Perform Rating
Provider: RODMAN & RENSHAW, CO.